NAD+ (1000mg) Biofermented (5ml Vial)
$69.99
1195 in stock
1195 in stock
Share on facebook
Facebook
Share on twitter
X
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
- NAD+ (1000mg) Biofermented (5ml Vial) is a vital coenzyme involved in essential cellular processes such as ATP production, DNA repair, and enzyme function, making it an important compound in cutting-edge biological research.
- Produced through a biofermentation process, this formulation ensures high purity and consistency, providing dependable results in studies related to metabolism and cellular function.
- NAD+ has been widely explored for its role in promoting healthy aging, mitochondrial efficiency, and cellular renewal, making it a key focus in longevity and age-related research models.
- Maintaining adequate NAD+ levels is central to investigating its impact on oxidative stress, inflammation regulation, and sirtuin activation—critical pathways linked to vitality and metabolic resilience.
- Supplied as a lyophilized powder in a 5ml vial for reconstitution, NAD+ (1000mg) Biofermented is intended for research use, offering versatility across a wide range of experimental applications.
Related Products
SUBSCRIBE & SAVE
Sign up below and be the first to know about new products and upcoming promotions!
CONTACT INFO
Quick links
SHIPPING DAYS
Monday to Friday Expect 48 hours for order processing and 7 days (or more) for delivery
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
All products are sold in powder (lyophilized) form and require reconstitution with a suitable diluent. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
Reviews
There are no reviews yet.